BusinessAlzheimer’s Foundation of America’s Medical, Scientific and Memory Screening Advisory Board to Develop New Recommendations to Further the Fight Against Alzheimer’sBy Nasdaq OMXSep 21, 2017, 6:06 PM UTC
BusinessCognition Therapeutics CEO Kenneth I. Moch to Present at Ladenburg Thalmann 2017 Healthcare ConferenceBy Nasdaq OMXSep 20, 2017, 12:00 PM UTC
BusinessFunction of Cognition Therapeutics’ Neurological Drug Screening Platform Presented at American Chemical Society National MeetingBy Nasdaq OMXAug 23, 2017, 1:45 PM UTC
BusinessCognition Therapeutics Elects Lazard Vice Chairman Stephen Sands to Board of DirectorsBy Nasdaq OMXAug 2, 2017, 12:00 PM UTC
BusinessCognition Therapeutics CEO Kenneth I. Moch to Present at Canaccord Genuity Annual Growth ConferenceBy Nasdaq OMXJul 31, 2017, 12:30 PM UTC
BusinessCognition Therapeutics Reports Drug-Drug Interaction Results for CT1812, a Disease-Modifying Alzheimer’s Disease CandidateBy Nasdaq OMXJul 19, 2017, 8:35 AM UTC
BusinessAxsome Therapeutics Initiates Phase 2/3 Trial of AXS-05 for Alzheimer’s Disease AgitationBy Nasdaq OMXJul 17, 2017, 11:00 AM UTC
BusinessWilliam Glass to Walk From Atlanta to Washington D.C. to Spread Alzheimer’s AwarenessBy Nasdaq OMXJun 29, 2017, 4:43 PM UTC
